RxDoctor Payments Data

Charles Johnson, MD

Clinical Cardiac Electrophysiology · Fort Collins, CONPI 1053317198

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,600 of the $12,331 with a category attached, or 61.6%. Abbott accounts for 82.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $8,331 and has fallen 96.1% since, to $327 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CO, where the typical reported total is $11,587.

$12,331in general payments, 2019–2025

Across 113 payments — averaging $109.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$10K
  • Boston Scientific$2K
  • Biotronik Inc.$494
  • Medtronic$25
  • E.r. Squibb & Sons, L.L.C.$14
  • Pfizer$14
  • plus $26 from 2 others

What the payments were for

  • Consulting fees$7,60062%
  • Travel & lodging$8867%
  • Food & beverage$3,84631%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,331 in reported general payments places this provider in the 50th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

See all clinical cardiac electrophysiology providers in Colorado

Medicare billing

Part B allowed, 2024
$291,892
Medicare patients
3,817
Services billed
6,965

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban276$365,829
XareltoRivaroxaban66$93,533
Flecainide Acetate60$4,544
Metoprolol Succinate118$2,266
Diltiazem 24hr Er (Cd)Diltiazem Hcl32$941
SotalolSotalol Hcl14$873
Amiodarone Hcl50$752
Warfarin Sodium52$601
JantovenWarfarin Sodium18$348
Metoprolol Tartrate32$181

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$365,829276 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

Other clinical cardiac electrophysiology in Fort Collins

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →